SCHEMBL3140244

SCHEMBL3140244

C=C(CCCNCCCC(=O)O)C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.42
SLC22A6 Q4U2R8 1/20 0.42
TSHR P16473 3/20 0.40
NFKB1 P19838 1/20 0.40
PMP22 Q01453 1/20 0.40
ALOX15 P16050 1/20 0.39
HSD17B10 Q99714 1/20 0.39
PRMT1 Q99873 1/20 0.39
CAMK2A Q9UQM7 1/20 0.37
ADRA1A P35348 1/20 0.36
S1PR1 P21453 2/20 0.36
S1PR3 Q99500 2/20 0.36
S1PR2 O95136 1/20 0.36
GABRR3 A8MPY1 1/20 0.36
GABRP O00591 1/20 0.36
GABRD O14764 1/20 0.36
HDAC3 O15379 1/20 0.36
GABBR2 O75899 1/20 0.36
CYP1A2 P05177 1/20 0.36
THRB P10828 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5086079 0.85 KDM4E (0.37) LMNAALOX15HSD17B10CAMK2AKMT2A
SCHEMBL2495440 0.85 CA12 (0.44) LMNATSHRPMP22ALOX15HSD17B10
SCHEMBL819365 0.85 CAMK2A (0.36) ALOX15HSD17B10CAMK2A
SCHEMBL33625 0.84 SLC22A6 (0.61) LMNASLC22A6TSHRNFKB1PMP22
SCHEMBL431916 0.84 LMNA (0.61) LMNASLC22A6TSHRNFKB1PMP22
SCHEMBL636292 0.83 PAOX (0.47) TSHRALOX15S1PR1S1PR3S1PR2
SCHEMBL246135 0.83 ALOX15 (0.45) TSHRALOX15S1PR1S1PR3S1PR2
SCHEMBL112741 0.83 LMNA (0.59) LMNASLC22A6TSHRNFKB1PMP22
SCHEMBL7779000 0.83 ALOX15 (0.34) ALOX15HSD17B10
SCHEMBL4276362 0.82 ALDH1A1 (0.50) TSHRALOX15S1PR1S1PR3S1PR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0751405-A2 Balanced charge polymer and hydrophilic contact lens manufactured therefrom Hydron Limited (GB) 1997-01-02 EP claimed
EP-0751404-A2 Balanced charge polymer and hydrophilic contact lens manufactured therefrom Hydron Limited (GB) 1997-01-02 EP claimed
EP-0751407-A2 Balanced charge polymer and hydrophilic contact lens manufactured therefrom Hydron Limited (GB) 1997-01-02 EP claimed
US-5391669-A Lens formed of water swellable crosslinked polymer containing polymer containing cationic-aninoic pair of unsaturated monomers and nonionic monomers HYDRON LIMITED (GB) 1995-02-21 US claimed
EP-0563299-A4 BALANCED CHARGE POLYMER AND HYDROPHILIC CONTACT LENS MANUFACTURED THEREFROM CESKOSLOVENSKA AKADEMIE VED (CS) 1994-07-20 EP claimed
US-5270415-A Balanced charge polymer and hydrophilic contact lens manufactured therefrom ALLERGAN INC. (US) 1993-12-14 US claimed
EP-0563299-A1 BALANCED CHARGE POLYMER AND HYDROPHILIC CONTACT LENS MANUFACTURED THEREFROM Hydron Limited (GB) 1993-10-06 EP claimed
WO-1992011301-A1 BALANCED CHARGE POLYMER AND HYDROPHILIC CONTACT LENS MANUFACTURED THEREFROM ALLERGAN, INC. (US) 1992-07-09 WO claimed
US-20100069544-A1 HYDROGEL CONTACT LENS COMPRISING A POLYMER COMPRISING A CARBOXY BETAINE ESTER MONOMER PROCORNEA HOLDING B.V. 2010-03-18 US disclosed
EP-2087397-A1 HYDROGEL CONTACT LENS COMPRISING A POLYMER COMPRISING A CARBOXY BETAINE ESTER MONOMER Procornea Holding B.V. (NL) 2009-08-12 EP disclosed
EP-1286823-B1 OPHTHALMIC LENSES AND COMPOSITIONS, AND METHODS FOR PRODUCING SAME COOPERVISION INT HOLDING CO LP (BB) 2009-06-17 EP disclosed
WO-2008066381-A1 HYDROGEL CONTACT LENS COMPRISING A POLYMER COMPRISING A CARBOXY BETAINE ESTER MONOMER PROCORNEA HOLDING B.V. (NL) 2008-06-05 WO disclosed
US-7262232-B2 Ophthalmic lenses and compositions and methods for producing same COOPERVISION, INC. (US) 2007-08-28 US disclosed
US-6992118-B2 Ophthalmic lenses and compositions and methods for producing same COOPER VISION INC. (US) 2006-01-31 US disclosed
EP-0751405-A2 Balanced charge polymer and hydrophilic contact lens manufactured therefrom Hydron Limited (GB) 1997-01-02 EP disclosed
EP-0751406-A2 Balanced charge polymer and hydrophilic contact lens manufactured therefrom Hydron Limited (GB) 1997-01-02 EP disclosed
EP-0751407-A2 Balanced charge polymer and hydrophilic contact lens manufactured therefrom Hydron Limited (GB) 1997-01-02 EP disclosed
EP-0751404-A2 Balanced charge polymer and hydrophilic contact lens manufactured therefrom Hydron Limited (GB) 1997-01-02 EP disclosed
US-5391669-A Lens formed of water swellable crosslinked polymer containing polymer containing cationic-aninoic pair of unsaturated monomers and nonionic monomers HYDRON LIMITED (GB) 1995-02-21 US disclosed
US-5270415-A Balanced charge polymer and hydrophilic contact lens manufactured therefrom ALLERGAN INC. (US) 1993-12-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069544-A1 HYDROGEL CONTACT LENS COMPRISING A POLYMER COMPRISING A CARBOXY BETAINE ESTER MONOMER CRYAA, CRYZ, CRYAB LMNA 1846/4885SLC22A6 1329/4885TSHR 2672/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.